Leveraging hallmark Alzheimer’s molecular targets using phytoconstituents: Current perspective and emerging trends
<p dir="ltr">Alzheimer's disease (AD), a type of dementia, severely distresses different brain regions. Characterized by various neuropathologies, it interferes with cognitive functions and neuropsychiatrical controls. This progressive deterioration has negative impacts not only...
محفوظ في:
| المؤلف الرئيسي: | Prajakta A. Dhage (17302789) (author) |
|---|---|
| مؤلفون آخرون: | Archana A. Sharbidre (17302792) (author), Sarada P. Dakua (17302795) (author), Shidin Balakrishnan (14150580) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
حسب: Nour K. Majbour (8809316)
منشور في: (2017) -
Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review
حسب: Shahd Abubaker Elamin (22569539)
منشور في: (2025) -
Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice
حسب: Ann Van der Jeugd (18629695)
منشور في: (2018) -
Tau deletion promotes brain insulin resistance
حسب: Elodie Marciniak (18892114)
منشور في: (2017) -
Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
حسب: Christopher Hatton (9107257)
منشور في: (2020)